{
  "document_id": "HOUSE_OVERSIGHT_026750",
  "filename": "IMAGES-009-HOUSE_OVERSIGHT_026750.txt",
  "text": "Select Summit Partners\n\nELEKTA\nVIRONOVA\nASTRAZENECA\nTORREYA PARTNERS\nNASDAQ STOCKHOLM\nMANNHEIMER SWARTLING\nBOSTON CONSULTING GROUP\nEMBASSY OF THE U.S. TO SWEDEN\nACCESS HEALTH INTERNATIONAL\nSKANDINAVISKA ENSKILDA BANKEN\nEMBASSY OF SWEDEN TO THE U.S.\nSCANDINAVIAN AIRLINES\nPHILIPS HEALTHCARE\nDUHAAN GROUPE\nRECIPHARM\nVINNOVA\nPFIZER\nEY\n\nOrganizers\nBARBRO C, EHNBOM, Founder & Chairman\nYLVA NICOLAE SANTESSON, Senior Project Manager\n\nSALSS 2017 TEAM\n\nwww.salss.com\n\nKK\n\nSenior Advisory Board\nDR. ROBERT LANGER, David H. Koch Institute Professor, MIT\nMR. FREDERICK FRANK, Chairman, EVOLUTION Life Science Partners\nDR. WILLIAM A. HASELTINE, Founder, Chairman & President, ACCESS Health International\nDR. HANS WIGZELL, Professor Emeritus, Karolinska Institutet\nDR, MATHIAS UHLEN, Professor, KTH | Director, Human Protein Atlas\nMR. MOHAMMED HOMMAN, Founder & CEO, Vironova\nDR. JENNI NORDBORG, Director & Head, Health Department, VINNOVA\nMR. RICHARD SERBIN, Founder & CEO, Seaweed Biotechnology\n\neK\n\nDR. CHARLES F, FERRIS, Special Scientific Advisor to the Chairman\nMR. PETER UTTERSTROM, Legal Advisor\nMS. LENA TIBELL, Program Advisor\n\nAMBASSADOR KARIN EHNBOM PALMQUIST, Chief of Protocol\n\nHOUSE_OVERSIGHT_026750",
  "metadata": {
    "original_filename": "IMAGES-009-HOUSE_OVERSIGHT_026750.txt",
    "source_dataset": "huggingface:tensonaut/EPSTEIN_FILES_20K",
    "character_count": 1202,
    "word_count": 162,
    "line_count": 50,
    "import_date": "2025-11-19T21:47:47.872288",
    "prefix": "IMAGES-009"
  }
}